Shields Matthew (CIK 2025621) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-22). Recent activity: Sell TEVA (9,989 shares), Buy TEVA (17,295 shares), Sell TEVA (17,295 shares), Buy TEVA (16,195 shares), Sell TEVA (6,206 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Global Operations | Sell | 9,989 | $321,547 |
| 2026-03-09 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Global Operations | Buy | 17,295 | $0 |
| 2026-03-09 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Global Operations | Sell | 17,295 | $547,733 |
| 2025-06-05 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Global Operations | Buy | 16,195 | $0 |
| 2025-06-05 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Global Operations | Sell | 6,206 | $105,626 |
Source: SEC Form 4 filings · as of 2026-06-22